These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identifying novel biomarkers for cardiovascular disease risk prediction. Ge Y; Wang TJ J Intern Med; 2012 Nov; 272(5):430-9. PubMed ID: 22950687 [TBL] [Abstract][Full Text] [Related]
5. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications. Pareek M Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244 [TBL] [Abstract][Full Text] [Related]
7. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease. Smith JG; Gerszten RE Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806 [TBL] [Abstract][Full Text] [Related]
8. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Wang TJ Circulation; 2011 Feb; 123(5):551-65. PubMed ID: 21300963 [No Abstract] [Full Text] [Related]
10. Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases. Dang VT; Huang A; Werstuck GH Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):166-175. PubMed ID: 29683098 [TBL] [Abstract][Full Text] [Related]
11. Novel Biomarkers for Predicting Cardiovascular Disease in Patients With Diabetes. Retnakaran R Can J Cardiol; 2018 May; 34(5):624-631. PubMed ID: 29287943 [TBL] [Abstract][Full Text] [Related]
12. Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar. Welsh P; Packard CJ; Sattar N Curr Opin Lipidol; 2008 Dec; 19(6):563-71. PubMed ID: 18957878 [TBL] [Abstract][Full Text] [Related]
13. Family history of coronary heart disease and markers of subclinical cardiovascular disease: where do we stand? Pandey AK; Pandey S; Blaha MJ; Agatston A; Feldman T; Ozner M; Santos RD; Budoff MJ; Blumenthal RS; Nasir K Atherosclerosis; 2013 Jun; 228(2):285-94. PubMed ID: 23578356 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Herder C; Karakas M; Koenig W Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741 [TBL] [Abstract][Full Text] [Related]
15. Novel Risk Markers and Risk Assessments for Cardiovascular Disease. Thomas MR; Lip GY Circ Res; 2017 Jan; 120(1):133-149. PubMed ID: 28057790 [TBL] [Abstract][Full Text] [Related]
16. Circulating cell-derived microparticles as biomarkers in cardiovascular disease. Thulin Å; Christersson C; Alfredsson J; Siegbahn A Biomark Med; 2016 Sep; 10(9):1009-22. PubMed ID: 27586235 [TBL] [Abstract][Full Text] [Related]
17. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease. Puntmann VO Postgrad Med J; 2009 Oct; 85(1008):538-45. PubMed ID: 19789193 [TBL] [Abstract][Full Text] [Related]
18. Novel biomarkers with potential for cardiovascular risk reclassification. Mallikethi-Reddy S; Briasoulis A; Akintoye E; Afonso L Biomarkers; 2017; 22(3-4):189-199. PubMed ID: 27299923 [TBL] [Abstract][Full Text] [Related]
19. Markers of Atherosclerosis: Part 2 - Genetic and Imaging Markers. Tibaut M; Caprnda M; Kubatka P; Sinkovič A; Valentova V; Filipova S; Gazdikova K; Gaspar L; Mozos I; Egom EE; Rodrigo L; Kruzliak P; Petrovic D Heart Lung Circ; 2019 May; 28(5):678-689. PubMed ID: 30318392 [TBL] [Abstract][Full Text] [Related]